Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation.

导出原文传递

翻译打印收藏纠错

作者： Charles F,Barish ^[1] ; Robert A,Crozier ^[2] ; Patrick H,Griffin ^[3]

作者单位： Wake Gastroenterology/Wake Research Associates, Raleigh, NC, USA. ^[1] Department of Gastroenterology, UNC School of Medicine, Chapel Hill, NC, USA. ^[2] Synergy Pharmaceuticals Inc., New York, NY, USA. ^[3]

关键词 Irritable bowel syndrome with constipation Long-term Plecanatide Safety Tolerability

主题词青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);便秘(Constipation);腹泻(Diarrhea);女(雌)性(Female);人类(Humans);肠易激综合征(Irritable Bowel Syndrome);男(雄)性(Male);中年人(Middle Aged);促尿钠排泄肽类(Natriuretic Peptides);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1080/03007995.2018.1527303

PMID 30277094

发布时间 2020-04-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Current medical research and opinion

2019年35卷1期

81-85页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation.

Current medical research and opinion

相似文献

Current medical research and opinion

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation.

Current medical research and opinion

相似文献

Current medical research and opinion

相关期刊

检索历史清除